Cozad Asset Management’s Quest Diagnostics DGX Stock Holding History

Cozad Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.76M	Buy	13,024 +1,495	+13%	+$293K	0.18%	121
2026 Q1	$2.26M	Buy	11,529 +1,022	+10%	+$199K	0.18%	127
2025 Q4	$1.82M	Buy	+10,507	New	+$1.91M	0.14%	151
2024 Q1	–	Sell	-10,426	Closed	-$1.44M	–	397
2023 Q4	$1.44M	Sell	10,426 -1,021	-9%	-$134K	0.17%	145
2023 Q3	$1.39M	Sell	11,447 -1,586	-12%	-$211K	0.18%	134
2023 Q2	$1.83M	Sell	13,033 -246	-2%	-$33.9K	0.23%	113
2023 Q1	$1.88M	Sell	13,279 -2,847	-18%	-$407K	0.25%	114
2022 Q4	$2.52M	Buy	16,126 +2,172	+16%	+$312K	0.35%	78
2022 Q3	$1.71M	Buy	+13,954	New	+$1.84M	0.28%	104

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Cozad Asset Management's DGX Position: Q2 2026 in Review

Cozad Asset Management increased its Quest Diagnostics (DGX) stake by 13% in Q2 2026, buying an estimated $293K and bringing the position to 13,024 shares worth $2.76M. The position accounts for 0.18% of the portfolio, ranked #121.

Cozad Asset Management first reported a position in DGX in Q3 2022 and has held it in 9 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Cozad Asset Management held 13,024 shares of Quest Diagnostics worth $2.76M as of Q2 2026.
Cozad Asset Management bought 1,495 Quest Diagnostics shares in Q2 2026, an estimated $293K.
Quest Diagnostics made up 0.18% of Cozad Asset Management's portfolio in Q2 2026, its #121 holding.
Cozad Asset Management first reported a position in Quest Diagnostics in Q3 2022 and has held it in 9 quarters since.
1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cozad Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.